Zobrazeno 1 - 10
of 26
pro vyhledávání: '"M Amenedo Gancedo"'
Autor:
Giovanni Scambia, Andrew R Clamp, Robert L. Coleman, T Kwan, Robert W. Holloway, Nicoletta Colombo, Lara Maloney, M. Amenedo Gancedo, Alexandra Leary, Peter C.C. Fong, Carol Aghajanian, David M. O'Malley, Johanne I Weberpals, Sandra Goble, Ana Oaknin, Jonathan A. Ledermann, Andrew Dean, Domenica Lorusso, Amit M. Oza, Jeffrey C. Goh
Publikováno v:
Oral Abstracts.
Autor:
M. Amenedo Gancedo, Andrew R Clamp, Nicoletta Colombo, Susana Banerjee, Domenica Lorusso, Giovanni Scambia, Johanne I Weberpals, Deborah K. Armstrong, T. Cameron, Sandra Goble, Jesús García-Donas, Lara Maloney, Ana Oaknin, Carol Aghajanian, Amit M. Oza, Robert W. Holloway, David M. O'Malley, Elizabeth M. Swisher, Andrew Dean, Jeffrey C. Goh, Jonathan A. Ledermann, P.C. Fong, Robert L. Coleman, Alexandra Leary
Publikováno v:
Oral Plenary.
Introduction In ARIEL3 (NCT01968213), rucaparib maintenance for recurrent ovarian cancer (rOC) significantly improved investigator-assessed PFS and postprogression efficacy outcomes versus placebo regardless of biomarker status. PFS was also improved
Autor:
T. Cameron, Nicoletta Colombo, Robert L. Coleman, Giovanni Scambia, Elizabeth M. Swisher, Ana Oaknin, Jeffrey C. Goh, J García-Donas, David M. O'Malley, Johanne I Weberpals, M. Amenedo Gancedo, Amit M. Oza, Peter C.C. Fong, Carol Aghajanian, Andrew Dean, Andrew R Clamp, Jonathan A. Ledermann, Alexandra Leary, Susana Banerjee, Domenica Lorusso, Sandra Goble, D. K. Armstrong, Robert W. Holloway, Lara Maloney
Publikováno v:
Oral Communication 3 – Ovarian Cancer.
Introduction/Background In ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo in all patient populations, regardless of biomarker status (Coleman et al. Lancet. 2017;390:1949–61). This subgroup
Autor:
M. Amenedo Gancedo, Nicoletta Colombo, Andrew R Clamp, Robert L. Coleman, Elizabeth M. Swisher, Susana Banerjee, Domenica Lorusso, Robert W. Holloway, Peter C.C. Fong, T. Cameron, Carol Aghajanian, Johanne I Weberpals, Jeffrey C. Goh, Josh Bedel, Jonathan A. Ledermann, David M. O'Malley, Amit M. Oza, Juliette Meunier, Ana Oaknin, J García-Donas, Giovanni Scambia, Andrew Dean, Sandra Goble, Alexandra Leary, D. K. Armstrong, Lara Maloney
Publikováno v:
Oral Communication 3 – Ovarian Cancer.
Introduction/Background Maintenance therapy for recurrent ovarian cancer is intended to extend progression-free survival (PFS) without compromising patient quality of life; therefore, the clinical benefits of prolonged PFS should be evaluated in the
Autor:
G. Huidobro Vence, C. Azpitarte Raposeiras, M. Caeiro Muñoz, F. J. Afonso Afonso, J. Casal Rubio, B. Taboada Valladares, M. Lázaro Quintela, J.L. Firvida Perez, B. Campos Balea, J. García Gonzalez, J. E. Castro Gomez, S. Vazquez Estevez, M. Amenedo Gancedo, M. Costa Rivas
Publikováno v:
Clinical and Translational Oncology. 20:1467-1473
The aim of this phase II study was to evaluate the activity and safety of the combination of cisplatin and vinorelbine with thoracic radiotherapy in unresectable locally advanced stage III non-small cell lung cancer (NSCLC). The primary endpoint was
Autor:
D.M. O'Malley, A.M. Oza, D. Lorusso, C. Aghajanian, A. Oaknin, A. Dean, N. Colombo, J.I. Weberpals, A.R. Clamp, G. Scambia, A. Leary, R.W. Holloway, M. Amenedo Gancedo, P.C. Fong, J.C. Goh, D.K. Armstrong, S. Banerjee, J. García-Donas, E.M. Swisher, T. Cameron, L. Maloney, S. Goble, K.K. Lin, J.A. Ledermann, R.L. Coleman
Publikováno v:
Gynecologic Oncology. 159:74-75
Autor:
Robert L. Coleman, Giovanni Scambia, Andrew R Clamp, Nicoletta Colombo, Carol Aghajanian, Alexandra Leary, Domenica Lorusso, Andrew Dean, T. Cameron, Ana Oaknin, Jeffrey C. Goh, P.C. Fong, Lara Maloney, Jonathan A. Ledermann, M. Amenedo Gancedo, David M. O'Malley, Robert W. Holloway, Johanne I Weberpals, Sandra Goble, Amit M. Oza
Publikováno v:
Annals of Oncology. 31:S620-S621
Autor:
Andrew R Clamp, Jonathan A. Ledermann, Nicoletta Colombo, Robert L. Coleman, Andrew Dean, Giovanni Scambia, Robert W. Holloway, Sandra Goble, Domenica Lorusso, Ana Oaknin, Peter C.C. Fong, Carol Aghajanian, David M. O'Malley, Lara Maloney, M. Amenedo Gancedo, Amit M. Oza, Alexandra Leary, T. Cameron, Jeffrey C. Goh, Johanne I Weberpals
Publikováno v:
Annals of Oncology. 30:v408-v409
Autor:
Josh Bedel, Andrew R Clamp, T. Cameron, Peter C.C. Fong, Giovanni Scambia, Sandra Goble, Carol Aghajanian, Andrew Dean, Johanne I Weberpals, Jeffrey C. Goh, Ana Oaknin, Nicoletta Colombo, Domenica Lorusso, Robert L. Coleman, M. Amenedo Gancedo, Jonathan A. Ledermann, Alexandra Leary, Robert W. Holloway, David M. O'Malley, Amit M. Oza
Publikováno v:
Plenary sessions.
Objectives In ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo. A prespecified exploratory analysis investigated postprogression outcomes. Additionally, a post hoc exploratory analysis investig
Autor:
Ana Oaknin, Giovanni Scambia, Peter C.C. Fong, Susana Banerjee, Domenica Lorusso, Terri Cameron, Andrew Dean, Jonathan A. Ledermann, Sandra Goble, Nicoletta Colombo, Robert L. Coleman, Amit M. Oza, Robert W. Holloway, M. Amenedo Gancedo, F.J. Backes, Carol Aghajanian, Alexandra Leary, Johanne I Weberpals, Andrew R Clamp, Jeffrey C. Goh
Publikováno v:
Gynecologic Oncology. 154:4-5